PANORAMA 2: A phase II study of panobinostat (LBH589) in combination with bortezomib (BTZ) and dexamethasone (DEX) in patients with relapsed and BTZ-refractory multiple myeloma (MM)

被引：3

作者：

Alsina, M.

Lonial, S.

Weber, D. M.

Coutre, S. E.

Kang, B. P.

Glynos, T.

Warsi, G.

Snodgrass, S. M.

Richardson, P. G.

机构：

[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA

[5] Novartis Pharmaceut, E Hanover, NJ USA

[6] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.tps308

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS308

引用

页数：1